Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28246706 | 0.98 | HIF1A (0.55) | SMN1; SMN2HIF1ASLC6A2TAAR1CYP3A4 | |
| SCHEMBL28727407 | 0.98 | SMN1; SMN2 (0.55) | SMN1; SMN2HIF1ASLC6A2TAAR1CYP3A4 | |
| SCHEMBL30853559 | 0.90 | TRPA1 (0.49) | SMN1; SMN2HIF1ASLC6A2TAAR1CYP3A4 | |
| SCHEMBL5171029 | 0.88 | ABCC4 (0.52) | SMN1; SMN2HIF1ACYP2C9ALDH1A1LMNA | |
| SCHEMBL14740848 | 0.87 | CYP1A2 (0.45) | SMN1; SMN2HIF1ASLC6A2TAAR1CYP3A4 | |
| SCHEMBL1147656 | 0.86 | SLC6A2 (0.52) | SMN1; SMN2HIF1ASLC6A2TAAR1CYP3A4 | |
| SCHEMBL29368049 | 0.85 | CYP1A2 (0.44) | SMN1; SMN2HIF1ACYP3A4CYP2C19PPARG | |
| SCHEMBL6722173 | 0.84 | SMN1; SMN2 (0.50) | SMN1; SMN2HIF1ASLC6A2TAAR1CYP3A4 | |
| SCHEMBL27925093 | 0.84 | ESR1 (0.56) | SMN1; SMN2HIF1ACYP3A4PPARGPPARA | |
| SCHEMBL8759 | 0.84 | SLC6A2 (0.56) | SMN1; SMN2HIF1ASLC6A2TAAR1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 740 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114901653-B | Novel amide derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof | 株式会社LG化学 | 2024-11-22 | — | — | CN | claimed |
| CN-114901653-A | Novel amide derivatives useful as diacylglycerol acyltransferase 2 inhibitors and uses thereof | 株式会社LG化学 | 2022-08-12 | — | — | CN | claimed |
| EP-3387099-B1 | FOOD CONTACT SURFACE SANITIZING LIQUID | CLOROX CO (US) | 2021-07-21 | — | — | EP | claimed |
| EP-3688124-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | ExxonMobil Chemical Patents Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-14 | — | — | US | claimed |
| EP-3423028-B1 | METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS | SYMRISE AG (DE) | 2020-04-08 | — | — | EP | claimed |
| EP-3006547-B1 | FRAGRANCE-CONTAINING CAPSULE AND COSMETIC IN WHICH SAID CAPSULES ARE BLENDED | SHISEIDO CO LTD (JP) | 2019-10-30 | — | — | EP | claimed |
| WO-2019067061-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-04-04 | — | — | WO | claimed |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-04-04 | — | — | US | claimed |
| EP-3423028-A1 | METHOD FOR THE PRODUCTION OF SCENT CAPSULES WITH IMPROVED SURFACTANT STABLITY | Symrise AG (DE) | 2019-01-09 | — | — | EP | claimed |
| US-20180119045-A1 | HIGH VISCOSITY INDEX MONOMETHYL ESTER LUBRICATING OIL BASE STOCKS AND METHODS OF MAKING AND USE THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2018-05-03 | — | — | US | claimed |
| WO-2017116900-A1 | HIGH VISCOSITY INDEX MONOMETHYL ESTER LUBRICATING OIL BASE STOCKS AND METHODS OF MAKING AND USE THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2017-07-06 | — | — | WO | claimed |
| EP-1716159-B1 | BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | MOMENTIVE PERFORMANCE MAT INC (US) | 2011-07-13 | — | — | EP | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-6451334-B2 | PULSE ADMINISTERING OF A C1-C4 SUBSTITUTED AND/OR PHENYL SUBSTITUTED CARBOXYLIC ACID AND SALTS AND A CARRIER OR DILUENT TO STIMULATE CELLS IN TREATING BLOOD DISORDERS, E.G. SICKLE CELL ANEMIA, THALASSEMIA, BLOOD LOSS ETC. | Perrine, Susan P. | 2002-09-17 | — | — | US | claimed |
| EP-0812538-B1 | Preservative compositions | ANGUS CHEMICAL (US) | 2001-01-03 | — | — | EP | claimed |
| EP-0861072-A2 | COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1998-09-02 | — | — | EP | claimed |
| WO-1996027369-A9 | COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS | — | 1996-12-27 | — | — | WO | claimed |
| WO-1996027369-A2 | COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS | THE TRUSTEES OF BOSTON UNIVERSITY (US) | 1996-09-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | ELOVL1, NOTUM, ELOVL5 | SMN1; SMN2 853/4885HIF1A 4509/4885SLC6A2 3650/4885 |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | ELOVL1, NOTUM, ELOVL5 | SMN1; SMN2 853/4885HIF1A 4509/4885SLC6A2 3650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.